Metformin, a hypoglycemic drug, increases peripheral glucose uptake, decreases liver glucose production and suppresses insulin resistance in liver and skeletal muscle. The molecular anti-inflammatory mechanism of metformin involves the reduction of the level of proinflammatory cytokines through AMPK activation. It can reduce endothelial dysfunction by ameliorating the expression of inflammatory gene and protein like vascular cell adhesion molecule-1 (VCAM-1), and vasodilating maternal vessels. Many studies showed that AMPK activation were the main contributors to the antioxidant and anti-inflammatory effects of metformin.
Metformin; a mini-review to its antioxidative and anti-inflammatory properties
A. Abbaszadeh,Sahar Koushki,Shirin Koushki,Marzieh Eskandarzadeh,A. Hasanvand
Published 2017 in Journal of renal injury prevention
ABSTRACT
PUBLICATION RECORD
- Publication year
2017
- Venue
Journal of renal injury prevention
- Publication date
2017-11-28
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-26 of 26 references · Page 1 of 1
CITED BY
Showing 1-3 of 3 citing papers · Page 1 of 1